Novavax, Inc. (NVAX) vs Ocular Therapeutix, Inc. (OCUL)
- Novavax, Inc. NVAX 7.95 −1.36%
- Ocular Therapeutix, Inc. OCUL 6.01 0.00%
Novavax, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Novavax, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.3B and $1.3B). Ocular Therapeutix, Inc. grew revenue faster over the last twelve months: −9.68% against −61.3%. Novavax, Inc. has the higher net margin (−18.6% vs −648.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Novavax, Inc. leads on 12 and Ocular Therapeutix, Inc. on 4.
Valuation
Profitability
| Metric | NVAX | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.01% | 87.32% | 70.18% |
| Operating margin | (21.23%) | (680.91%) | 0.00% |
| Net margin | (18.64%) | (648.64%) | 0.00% |
| Free cash flow margin | (59.25%) | (530.00%) | 0.00% |
| Return on equity | 41.08% | (93.48%) | (50.72%) |
| Return on assets | (7.42%) | (64.30%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack